Eli Lilly and Company holds the ownership of Mounjaro [1]. Mounjaro is a medication approved for the treatment of type 2 diabetes [2].
What is Mounjaro used for?
Mounjaro (tirzepatide) is a medication indicated to improve glycemic control in adults with type 2 diabetes mellitus [2]. It is also being investigated for other indications, including obesity [3].
How does Mounjaro work?
Mounjaro is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. By activating both receptors, tirzepatide helps to lower blood glucose levels and promote weight loss [4].
When does Mounjaro's patent expire?
Information on Mounjaro's patent expiry dates can be found on DrugPatentWatch.com [5]. Patent exclusivity is crucial for pharmaceutical companies as it determines the period during which generic versions of the drug cannot be marketed.
Who are Mounjaro's competitors?
Mounjaro competes in the diabetes and weight loss market with other GLP-1 receptor agonists and dual agonists. Key competitors include semaglutide (Ozempic, Wegovy) manufactured by Novo Nordisk, and other GLP-1 receptor agonists like liraglutide (Victoza, Saxenda) [6].
What clinical data supports Mounjaro's use?
Clinical trials have demonstrated Mounjaro's efficacy in reducing A1C levels and body weight in individuals with type 2 diabetes [2, 4]. These studies have provided the basis for its regulatory approvals [2].
What are the potential side effects of Mounjaro?
Common side effects of Mounjaro include gastrointestinal issues such as nausea, vomiting, diarrhea, and constipation. More serious, though less common, side effects can occur [2].
Can Mounjaro be used for weight loss?
While Mounjaro is approved for type 2 diabetes, tirzepatide has shown significant weight loss effects. Eli Lilly has sought and obtained approval for tirzepatide for chronic weight management in individuals with obesity or overweight with at least one weight-related condition [3].
What is the price of Mounjaro?
The price of Mounjaro can vary based on insurance coverage, pharmacy, and location. Information on drug pricing is typically available through pharmacies and insurance providers [7].
What are the regulatory approvals for Mounjaro?
Mounjaro has received approval from regulatory agencies, such as the U.S. Food and Drug Administration (FDA), for its indicated uses [2].
---
Sources:
[1] Eli Lilly and Company. (n.d.). Eli Lilly and Company. Retrieved from https://www.lilly.com/
[2] Mounjaro Prescribing Information. (n.d.). U.S. Food and Drug Administration.
[3] Eli Lilly and Company. (2023, November 8). Eli Lilly announces U.S. FDA approval of Zepbound™ (tirzepatide) for chronic weight management [Press release].
[4] Frias JP, Davies MJ, Stone L, et al. Tirzepatide versus Semaglutide Once Weekly in Patients With Type 2 Diabetes. N Engl J Med. 2021;385(6):503-515. doi:10.1056/NEJMoa2107519
[5] DrugPatentWatch.com. (n.d.). Retrieved from https://drugpatentwatch.com/
[6] Novo Nordisk. (n.d.). Novo Nordisk. Retrieved from https://www.novonordisk.com/
[7] GoodRx. (n.d.). Mounjaro Prices, Coupons, and Patient Assistance Programs. Retrieved from https://www.goodrx.com/mounjaro